Formulation: A crystalline solid
Formal Name: D-alanyl-L-seryl-L-threonyl-L-threonyl-L-threonyl-L-asparaginyl-L-tyrosyl-L-threoninamide, acetate
Purity: ≥98%
Formula Markup: C35H56N10O15 • XC2H4O2
Formula Weight: 856,9
Shelf life (days): 1460
Notes: DAPTA is a peptide antagonist of chemokine (C-C motif) receptor 5 (CCR5).{58389} It inhibits CD4-dependent binding of HIV-1Ba-L and HIV-1CM235 gp120 envelope proteins to CCR5 (IC50s = 0.06 and 0.32 nM, respectively). DAPTA (0.1 mg/kg, i.p.) reduces marble burying and repetitive behavior, as well as decreases brain levels of IL-6, IL-9, and IL-17A, in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorder (ASD).{58391} It also reduces LPS-induced microglial activation and astrocyte hypertrophy in the dentate gyrus in a rat model of chronic neuroinflammation.{58390}